William DeVaul - 14 Jan 2022 Form 4 Insider Report for Morphic Holding, Inc.

Reporting relationship: General Counsel and Secretary
Issuer ticker: N/A
Reported as of: 14 Jan 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 19 Jan 2022, 18:06:46 UTC
Prior SEC filing: 30 Dec 2021
Next SEC filing: 18 Jan 2023
Source filing: View source filing
Reporting owner signature: /s/ Robert Farrell as attorney-in-fact for William D. DeVaul

Key filing fact

William DeVaul filed Form 4 for Morphic Holding, Inc. on 19 Jan 2022.

Key facts

This page summarizes William DeVaul's Form 4 filing for Morphic Holding, Inc..
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 19 Jan 2022, 18:06.

Change

Previous filing in this sequence was filed on 30 Dec 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MORF transaction Derivative

Stock Option (right to buy Common Stock)

Award

Transaction value: $0
Shares: +57,792
Change %
Price: $0.000000
Shares after: 57,792
Date: 14 Jan 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 57,792
Exercise price: $44.75
Footnotes: F1

MORF transaction Derivative

Restricted Stock Units (RSU)

Award

Transaction value: $0
Shares: +13,000
Change %
Price: $0.000000
Shares after: 13,000
Date: 14 Jan 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 13,000
Exercise price
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The option vests as to 2.0833% of the total shares monthly, beginning February 14, 2022, with 100% of the total shares vested and exercisable on January 14, 2026, subject to the reporting person's provision of service to the issuer on each vesting date.

Footnote F2

Each RSU represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.

Footnote F3

The RSUs vest as to 25% of the total shares on each of January 14, 2023, January 14, 2024, January 14, 2025, and January 14, 2026, subject to the reporting person's provision of service to the issuer on each vesting date.